Zydus receives EIR Report for manufacturing facility at Pharma SEZ at Ahmedabad

29 Aug 2017 Evaluate

Zydus Cadila’s formulations manufacturing facility at the Pharma SEZ at Ahmedabad has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) signifying the successful closure of the Audit. The manufacturing plant had completed the USFDA Audit from 16 to 24 January 2017.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Zydus Lifesciences Share Price

913.90 -7.35 (-0.80%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×